LOS ANGELES--(BUSINESS WIRE)--John Wayne Cancer Institute at Saint John’s Health Center, the National Institutes of Health (NIH) and Children’s Hospital Los Angeles (CHLA) have granted CerRx Inc., worldwide exclusive rights to intellectual property and know-how related to a novel formulation of a Vitamin A analog to treat cancer, as a single agent or in combination with partnering agents.
